Purchase Order 75N95024P00088
Award Date
7/3/24
Potential Completion Date
7/2/25
Potential Value
$199K
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian federal agency, awarded a $10,000.00 firm-fixed price purchase order to Darryle Schoepp for Biological Therapeutics Consultation Services. The award has a completion date of July 1, 2025 and was made on July 2, 2024. There is no set-aside designation for this contract. The contract is for the provision of consultation services related to biological therapeutics, which aligns with NINDS's mission of supporting...
The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $20,446 purchase order to Eurofins Discoverx Corporation of Fremont, California. Under the firm fixed price contract, Eurofins will provide GPCRMAX PANEL services to NIH NINDS from August 2023 through December 2023. As a leading provider of drug discovery services, Eurofins will support NINDS's work to understand, treat, and prevent disorders of the brain...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $462,900.00 contract to The Conjugate Group LLC, a small disadvantaged business, to provide regulatory affairs consultant support services. The contract has a base period of one year beginning September 2023 with two optional one-year extensions. The services are in support of the NIH Blueprint Neurotherapeutics program and the NIH HEAL Pain Therapeutics Development Program, as well as other NINDS...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $14,800.00 firm-fixed-price purchase order to Molecular Devices LLC, a division of Danaher Corporation, for the procurement of one Molecular Devices Digidata 1550B1 Low Noise Data Acquisition System. This system is required to support the NINDS Neurovascular Research Unit's research on neurovascular coupling mechanisms and functional...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $568,500.00 purchase order contract to Araldi Gian Luca, a sole proprietorship providing scientific research and development services. This contract is for pharmaceutics formulation/chemistry manufacturing and control consulting services for small molecules and/or biologics in support of the NINDS's neuroscience drug discovery and development programs, including the National Institutes of Health's (NIH) Blueprint...
The Department of Health and Human Services' National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $20,446.64 firm fixed price purchase order to Eurofins Discoverx Corporation of Fremont, California. The purchase order is for GPCRMAX PANEL services and will be performed between June 26, 2023 and September 30, 2023 in Fremont. The National Institute of Neurological Disorders and Stroke supports research on brain and nervous system disorders to reduce...
The National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, awarded a firm fixed price purchase order contract to 10X Genomics, Inc. for the provision of 10X Genomics RNA sequencing kits. The $40,289.50 contract has an ultimate completion date of October 25, 2020. There was no set-aside designation used for this award. The contract was issued under a larger indefinite delivery contract valued at up to $750,000...
This is a $1,485,008.40, firm-fixed-price contract awarded by the National Institute on Drug Abuse (NIDA), on behalf of the National Institute of Neurological Disorders and Stroke (NINDS), to Curia Global Inc. (doing business as Amri). The contract is for the non-GMP synthesis of up to 100 compounds in 2-10 milligram quantities to support a medicinal chemistry discovery program focused on identifying molecules that bind the KIAA0203 protein, which could potentially lead to the development of a...
This is a $473,586.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS) to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The contract, which does not have a set-aside designation, is part of NINDS's Pharmacology and Toxicology for Therapeutics Program and supports preclinical research activities, including toxicology studies and safety assessments of potential...
This is a federal contract award issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a non-profit division of the Illinois Institute of Technology. The $224,716.00 contract is a delivery order under a larger indefinite delivery/indefinite quantity (IDIQ) vehicle called the Pharmacology and Toxicology for Therapeutics Program, which has a total ceiling value...